Helm, Jessica S. http://orcid.org/0000-0002-1749-3775
Rudel, Ruthann A. http://orcid.org/0000-0002-1809-4127
Funding for this research was provided by:
California Breast Cancer Research Program (17UB-8708, 21UB-8012)
California Breast Cancer Research Program (21UB-8012, 21UB-8100)
Cedar Tree Foundation
Silent Spring Institute Innovation Fund
Avon Foundation for Women
Article History
Received: 11 March 2020
Accepted: 16 April 2020
First Online: 13 May 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: This manuscript is an original work, has not been previously published in whole or in part in a peer-reviewed journal, and is not under consideration for publication in another peer-reviewed journal. A more extensive description of this AOP containing over 30,000 words and 500 references has been entered into the OECD's online AOP wiki (aopwiki.org) and will be submitted to review by the Extended Advisory Group on Molecular Screening and Transcriptomics for publication in the OECD series on adverse outcome pathways. Both of the authors have read and approved the paper, and it has not been published previously nor is it being considered by any other peer-reviewed journal.
: Supplemental files to the manuscript contain key data extracted from the 467 articles that we reviewed.